Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Hydroxyurea and Thalidomide in Transfusion Dependent Thalassemia in Children
NCT06299670Phase 4Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Nov 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of thalidomide, hydroxyurea in thalassemia, sponsored by Bangabandhu Sheikh Mujib Medical University. Started Nov 2023; status: completed.
02
Drugs
thalidomidehydroxyurea
03
Conditions
thalassemia
Beyond the preview
Go deeper on NCT06299670.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06299670.